Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank93
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
7.64%
↑ 120% vs avg
Percentile
P93
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-38.37%
Historical baseline
PeriodValue
20257.64%
20245.22%
2023-22.65%
2022-17.95%
2021-5.39%
2020-51.94%
2019-61.85%
2018-28.48%
2017-133.22%
2016-75.11%